Sale!

SUFU Gene Meningioma Familial Susceptibility NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SUFU Gene Meningioma Familial Susceptibility NGS Genetic DNA Test is a cutting-edge genetic screening that identifies inherited mutations in the SUFU gene, which significantly increases the risk of developing meningioma brain tumors. Using Next-Generation Sequencing (NGS) technology, this comprehensive test provides crucial information about familial cancer predisposition, enabling proactive medical management and early intervention strategies. The test is particularly valuable for individuals with a family history of meningiomas or those diagnosed with multiple brain tumors. Results typically take 3-4 weeks and require a simple blood sample or extracted DNA. At just $500 USD, this test offers affordable access to advanced genetic cancer risk assessment, helping patients and their families make informed healthcare decisions.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SUFU Gene Meningioma Familial Susceptibility NGS Genetic DNA Test

Comprehensive Genetic Assessment for Inherited Meningioma Risk

The SUFU Gene Meningioma Familial Susceptibility NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment, specifically targeting inherited predisposition to meningioma brain tumors. Meningiomas are the most common primary brain tumors, and understanding genetic susceptibility can transform prevention and treatment strategies for at-risk individuals and families.

What This Advanced Genetic Test Measures

This sophisticated diagnostic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the SUFU gene for pathogenic mutations. The SUFU gene functions as a crucial tumor suppressor, and inherited mutations significantly elevate the risk of developing meningiomas and other associated tumors throughout an individual’s lifetime.

  • Comprehensive analysis of the entire SUFU gene coding regions
  • Detection of point mutations, small insertions, and deletions
  • Identification of inherited genetic variants associated with meningioma susceptibility
  • Assessment of tumor suppressor gene functionality

Who Should Consider This Genetic Test

This test is particularly recommended for individuals who meet specific clinical criteria indicating potential inherited meningioma susceptibility:

  • Individuals with a personal history of multiple meningiomas
  • Patients diagnosed with meningioma at a young age (under 45 years)
  • Those with a strong family history of meningiomas or brain tumors
  • Individuals with family members diagnosed with Gorlin syndrome (nevoid basal cell carcinoma syndrome)
  • Patients with personal or family history of other SUFU-related tumors
  • Individuals planning family who want to understand inherited cancer risks

Significant Benefits of Genetic Testing

Undergoing the SUFU Gene Meningioma Familial Susceptibility Test provides numerous advantages for comprehensive healthcare management:

  • Early Risk Identification: Detect genetic predisposition before tumor development
  • Personalized Surveillance: Implement targeted screening protocols for at-risk individuals
  • Family Planning Guidance: Make informed reproductive decisions based on genetic risk
  • Proactive Medical Management: Develop personalized prevention strategies
  • Family Member Screening: Identify at-risk relatives who may benefit from testing
  • Psychological Relief: Reduce uncertainty through definitive genetic information

Understanding Your Test Results

Our comprehensive genetic counseling ensures you fully understand your test results and their implications:

  • Positive Result: Indicates an inherited SUFU gene mutation, requiring enhanced surveillance and family member testing
  • Negative Result: No pathogenic SUFU mutation detected, though continued routine medical care is recommended
  • Variant of Uncertain Significance: Requires ongoing monitoring as research evolves
  • Personalized Management Plan: Each result includes specific recommendations for surveillance and prevention

Test Details and Pricing

Test Component Details
Test Name SUFU Gene Meningioma Familial Susceptibility NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure accurate interpretation and maximum benefit from your genetic testing:

  • Complete clinical history documentation
  • Mandatory genetic counseling session with our certified genetic counselors
  • Development of detailed family pedigree chart
  • Discussion of potential implications and limitations of testing
  • Informed consent process

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and medical professionals ensures consistent, high-quality care regardless of location.

Take Control of Your Genetic Health Today

Understanding your genetic predisposition to meningioma can be life-changing. Our comprehensive SUFU gene testing provides the clarity needed to make informed healthcare decisions and implement proactive management strategies. With our discounted price of $500 USD, advanced genetic testing is more accessible than ever.

Ready to begin your genetic health journey? Contact our expert genetic counseling team today at +1(267) 388-9828 or book your appointment online. Take the first step toward personalized cancer risk management and peace of mind for you and your family.